宏柏新材(605366) - 2025 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2025 was CNY 355,825,096.30, a decrease of 5.68% compared to CNY 377,270,519.57 in the same period last year[3] - The net profit attributable to shareholders was a loss of CNY 5,619,211.21, representing a decline of 179.42% from a profit of CNY 7,075,145.30 in the previous year[3] - The basic earnings per share decreased to -CNY 0.01, down 200.00% from CNY 0.01 in the same period last year[3] - The net cash flow from operating activities was -CNY 126,433,261.15, compared to -CNY 33,187,381.29 in the previous year, indicating a significant increase in cash outflow[3] - The decline in net profit was primarily due to lower sales prices of main products and increased interest expenses on convertible bonds[6] - The company reported a net profit of -6,468,429.36 RMB for Q1 2025, a significant decline compared to a net profit of 9,392,557.50 RMB in Q1 2024, indicating a year-over-year decrease of approximately 168.9%[30] - Operating profit for Q1 2025 was -9,645,914.98 RMB, contrasting with an operating profit of 9,305,190.04 RMB in Q1 2024, reflecting a substantial decline[30] Assets and Liabilities - Total assets at the end of the reporting period were CNY 4,095,162,635.26, a slight decrease of 0.05% from CNY 4,097,165,919.14 at the end of the previous year[4] - The company's total assets amounted to RMB 4,095,162,635.26, slightly down from RMB 4,097,165,919.14 at the end of 2024[12] - Total liabilities as of the latest reporting period were CNY 2,003,967,960.11, slightly up from CNY 1,995,847,080.21[14] - The total liabilities increased to CNY 2,278,568,865.61 from CNY 2,130,677,563.57 in the previous period[27] - The total equity attributable to shareholders was CNY 2,091,093,629.74, down from CNY 2,101,322,754.21[14] - The company's total equity decreased to CNY 2,001,954,097.99 from CNY 2,013,638,675.25[27] Cash Flow - Cash received from sales of goods and services in Q1 2025 was CNY 206,433,655.54, down from CNY 214,998,283.29 in Q1 2024[21] - The cash inflow from investment activities was CNY 253,665,249.92, compared to CNY 358,573.64 in the previous period[22] - The net cash flow from financing activities was CNY 92,522,715.52, down from CNY 136,840,713.79 in the previous period[23] - The company reported a net increase in cash and cash equivalents of CNY 98,563,262.20 for the period[23] - Cash flow from operating activities generated a net inflow of 29,284,335.58 RMB in Q1 2025, compared to a net outflow of -27,251,857.59 RMB in Q1 2024, marking a turnaround in operational cash flow[32] Costs and Expenses - Total operating costs for Q1 2025 were CNY 368,130,773.42, slightly down from CNY 376,898,102.18 in Q1 2024[17] - The operating cost for Q1 2025 was CNY 319,525,124.64, an increase of 2.1% from CNY 311,307,487.56 in Q1 2024[29] - Research and development expenses for Q1 2025 were CNY 13,122,243.80, up from CNY 10,057,800.30 in Q1 2024, indicating a focus on innovation[18] - The company incurred financial expenses of 9,425,414.35 RMB in Q1 2025, significantly higher than 4,471,524.53 RMB in Q1 2024, representing an increase of about 110.5%[30] Shareholder Information - The company reported a total of 137,646,667 shares held by Hongbo Chemical Co., Ltd., representing 21.68% of total shares[10] - The company has no significant changes in the participation of major shareholders in financing and securities lending activities[10] - There are no significant reminders for investors regarding the company's operational situation during the reporting period[11]